This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n10http://linked.opendata.cz/resource/drugbank/drug/DB04125/identifier/pubchem-compound/
n6http://linked.opendata.cz/resource/drugbank/drug/DB04125/identifier/pubchem-substance/
n13http://linked.opendata.cz/resource/drugbank/drug/DB04125/identifier/drugbank/
n14http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n9http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#
n11http://linked.opendata.cz/resource/drugbank/drug/DB04125/identifier/bindingdb/
n7http://linked.opendata.cz/resource/drugbank/drug/DB04125/identifier/pdb/

Statements

Subject Item
n2:DB04125
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n9:DB04125 n14:DB04125
dcterms:title
N-Alpha-(2-Naphthylsulfonyl)-N(3-Amidino-L-Phenylalaninyl)-4-Acetyl-Piperazine
adms:identifier
n6:46504514 n7:FD4 n10:178051 n11:50060038 n13:DB04125
n3:IUPAC-Name
n4:271B63C2-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B63C8-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B63C7-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B63C4-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B63C5-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B63C6-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B63C0-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B63BE-363D-11E5-9242-09173F13E4C5 n4:271B63C1-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B63BF-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B63CE-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B63CF-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B63C9-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B63CA-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B63CC-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B63CB-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B63CD-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B63D4-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B63D6-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B63D7-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B63D3-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B63D2-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B63D5-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B63C3-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B63D0-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B63D1-363D-11E5-9242-09173F13E4C5